Emzor Group announced its intention to significantly increase investments in local drug manufacturing and maternal health solutions, a critical move as Nigeria grapples with one of the world's highest rates of maternal mortality.
The company made this commitment on the occasion of the International Day for Maternal Health and Rights (IDMHR), highlighting that preventable deaths during childbirth remain a pressing public health concern in Nigeria.
Pharm. Uzoma Ezeoke, the executive director of Emzor Group, stressed the need for continuous action, stating, “Every woman deserves access to safe pregnancy, childbirth, and postnatal care. Maternal health should not be a privilege, it is a fundamental right. However achieving this requires deliberate investment, strong health systems, and collaboration across public and private sectors. Emzor stands proudly at this intersection, and today we use this opportunity to restate our commitment to improving maternal health outcomes.”
Kunle Faloye, head of marketing at Emzor, elaborated on the company's role, noting, “We are committed to supporting healthcare systems with high-quality, affordable pharmaceutical products that address critical maternal health needs, from nutrition and prenatal care to postpartum support. Our investments in local manufacturing are designed to improve access, ensure supply reliability, and ultimately deliver better outcomes for mothers and newborns. This spans both over-the-counter supplements and prescription medicines.”
Nigeria faces a stark reality with approximately 993 maternal deaths per 100,000 live births, a figure that represents nearly a third of all maternal deaths globally, according to the World Health Organization. This translates to over 200 daily deaths, with many attributed to preventable causes like postpartum haemorrhage.
To combat this crisis, Emzor is expanding the production of essential maternal health medicines via its subsidiary, Zolon Healthcare Limited. This includes treatments based on misoprostol, which are vital for managing and preventing excessive bleeding after childbirth.
